Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 09:27:16 UTC |
---|
Update Date | 2021-09-26 23:04:05 UTC |
---|
HMDB ID | HMDB0251827 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | ent-Rosuvastatin Lactone |
---|
Description | N-[4-(4-fluorophenyl)-5-[2-(4-hydroxy-6-oxooxan-2-yl)ethenyl]-6-(propan-2-yl)pyrimidin-2-yl]-N-methylmethanesulfonamide belongs to the class of organic compounds known as phenylpyrimidines. These are polycyclic aromatic compounds containing a benzene ring linked to a pyrimidine ring through a CC or CN bond. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. Based on a literature review very few articles have been published on N-[4-(4-fluorophenyl)-5-[2-(4-hydroxy-6-oxooxan-2-yl)ethenyl]-6-(propan-2-yl)pyrimidin-2-yl]-N-methylmethanesulfonamide. This compound has been identified in human blood as reported by (PMID: 31557052 ). Ent-rosuvastatin lactone is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically ent-Rosuvastatin Lactone is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=CC1CC(O)CC(=O)O1)N(C)S(C)(=O)=O InChI=1S/C22H26FN3O5S/c1-13(2)20-18(10-9-17-11-16(27)12-19(28)31-17)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)32(4,29)30/h5-10,13,16-17,27H,11-12H2,1-4H3 |
---|
Synonyms | Value | Source |
---|
N-[4-(4-Fluorophenyl)-5-[2-(4-hydroxy-6-oxooxan-2-yl)ethenyl]-6-(propan-2-yl)pyrimidin-2-yl]-N-methylmethanesulphonamide | Generator |
|
---|
Chemical Formula | C22H26FN3O5S |
---|
Average Molecular Weight | 463.52 |
---|
Monoisotopic Molecular Weight | 463.157720286 |
---|
IUPAC Name | N-[4-(4-fluorophenyl)-5-[2-(4-hydroxy-6-oxooxan-2-yl)ethenyl]-6-(propan-2-yl)pyrimidin-2-yl]-N-methylmethanesulfonamide |
---|
Traditional Name | N-[4-(4-fluorophenyl)-5-[2-(4-hydroxy-6-oxooxan-2-yl)ethenyl]-6-isopropylpyrimidin-2-yl]-N-methylmethanesulfonamide |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=CC1CC(O)CC(=O)O1)N(C)S(C)(=O)=O |
---|
InChI Identifier | InChI=1S/C22H26FN3O5S/c1-13(2)20-18(10-9-17-11-16(27)12-19(28)31-17)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)32(4,29)30/h5-10,13,16-17,27H,11-12H2,1-4H3 |
---|
InChI Key | SOEGVMSNJOCVHT-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenylpyrimidines. These are polycyclic aromatic compounds containing a benzene ring linked to a pyrimidine ring through a CC or CN bond. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazines |
---|
Sub Class | Pyrimidines and pyrimidine derivatives |
---|
Direct Parent | Phenylpyrimidines |
---|
Alternative Parents | |
---|
Substituents | - 4-phenylpyrimidine
- Delta valerolactone
- Fluorobenzene
- Halobenzene
- Delta_valerolactone
- Aryl fluoride
- Aryl halide
- Monocyclic benzene moiety
- Benzenoid
- Oxane
- Organosulfonic acid amide
- Organic sulfonic acid amide
- Heteroaromatic compound
- Aminosulfonyl compound
- Sulfonyl
- Organic sulfonic acid or derivatives
- Organosulfonic acid or derivatives
- Secondary alcohol
- Carboxylic acid ester
- Lactone
- Carboxylic acid derivative
- Oxacycle
- Azacycle
- Monocarboxylic acid or derivatives
- Organic oxide
- Organohalogen compound
- Organofluoride
- Alcohol
- Hydrocarbon derivative
- Organonitrogen compound
- Organooxygen compound
- Carbonyl group
- Organic nitrogen compound
- Organosulfur compound
- Organic oxygen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredictor | Adduct Type | CCS Value (Å2) | Reference |
---|
DeepCCS | [M+H]+ | 205.535 | 30932474 | DeepCCS | [M-H]- | 203.177 | 30932474 | DeepCCS | [M-2H]- | 236.233 | 30932474 | DeepCCS | [M+Na]+ | 211.628 | 30932474 |
Predicted Kovats Retention IndicesDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
ent-Rosuvastatin Lactone,1TMS,isomer #1 | CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C2=CC=C(F)C=C2)=C1C=CC1CC(O[Si](C)(C)C)CC(=O)O1 | 3442.8 | Semi standard non polar | 33892256 | ent-Rosuvastatin Lactone,1TMS,isomer #1 | CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C2=CC=C(F)C=C2)=C1C=CC1CC(O[Si](C)(C)C)CC(=O)O1 | 3499.9 | Standard non polar | 33892256 | ent-Rosuvastatin Lactone,1TMS,isomer #1 | CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C2=CC=C(F)C=C2)=C1C=CC1CC(O[Si](C)(C)C)CC(=O)O1 | 4773.7 | Standard polar | 33892256 | ent-Rosuvastatin Lactone,1TBDMS,isomer #1 | CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C2=CC=C(F)C=C2)=C1C=CC1CC(O[Si](C)(C)C(C)(C)C)CC(=O)O1 | 3621.7 | Semi standard non polar | 33892256 | ent-Rosuvastatin Lactone,1TBDMS,isomer #1 | CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C2=CC=C(F)C=C2)=C1C=CC1CC(O[Si](C)(C)C(C)(C)C)CC(=O)O1 | 3744.7 | Standard non polar | 33892256 | ent-Rosuvastatin Lactone,1TBDMS,isomer #1 | CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C2=CC=C(F)C=C2)=C1C=CC1CC(O[Si](C)(C)C(C)(C)C)CC(=O)O1 | 4778.6 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - ent-Rosuvastatin Lactone GC-MS (Non-derivatized) - 70eV, Positive | splash10-0007-7119500000-c8b6885faaf6182260f0 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - ent-Rosuvastatin Lactone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - ent-Rosuvastatin Lactone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - ent-Rosuvastatin Lactone 10V, Positive-QTOF | splash10-03di-0000900000-63515325fcb97c622d15 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - ent-Rosuvastatin Lactone 20V, Positive-QTOF | splash10-03di-0004900000-ad65335999d9c90032ea | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - ent-Rosuvastatin Lactone 40V, Positive-QTOF | splash10-00e9-0096100000-02fb2c3d4835faf0a16d | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - ent-Rosuvastatin Lactone 10V, Negative-QTOF | splash10-03di-0000900000-9f6f568c283be8b99a97 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - ent-Rosuvastatin Lactone 20V, Negative-QTOF | splash10-044i-3019800000-1e5ddc5376239a0eadf7 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - ent-Rosuvastatin Lactone 40V, Negative-QTOF | splash10-01u0-7119200000-054e7de481f1322af2c5 | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|